Amgen Inc (AMGN)
319.66
+2.18
(+0.69%)
USD |
NASDAQ |
Oct 04, 16:00
319.66
0.00 (0.00%)
After-Hours: 20:00
Amgen Shareholders Equity (Annual): 6.232B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 6.232B |
December 31, 2022 | 3.661B |
December 31, 2021 | 6.70B |
December 31, 2020 | 9.409B |
December 31, 2019 | 9.673B |
December 31, 2018 | 12.50B |
December 31, 2017 | 25.24B |
December 31, 2016 | 29.88B |
December 31, 2015 | 28.08B |
December 31, 2014 | 25.78B |
December 31, 2013 | 22.10B |
December 31, 2012 | 19.06B |
December 31, 2011 | 19.03B |
December 31, 2010 | 23.94B |
December 31, 2009 | 22.67B |
December 31, 2008 | 20.39B |
December 31, 2007 | 17.87B |
December 31, 2006 | 18.96B |
December 31, 2005 | 20.45B |
December 31, 2004 | 19.70B |
December 31, 2003 | 19.39B |
Date | Value |
---|---|
December 31, 2002 | 18.29B |
December 31, 2001 | 5.217B |
December 31, 2000 | 4.314B |
December 31, 1999 | 3.024B |
December 31, 1998 | 2.562B |
December 31, 1997 | 2.139B |
December 31, 1996 | 1.906B |
December 31, 1995 | 1.672B |
December 31, 1994 | 1.274B |
December 31, 1993 | 1.172B |
December 31, 1992 | 933.70M |
December 31, 1991 | 531.10M |
March 31, 1991 | 398.00M |
March 31, 1990 | 188.10M |
March 31, 1989 | 161.90M |
March 31, 1988 | 163.50M |
March 31, 1987 | 84.00M |
March 31, 1986 | 80.60M |
March 31, 1985 | 37.70M |
March 31, 1984 | 45.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
3.661B
Minimum
2022
9.673B
Maximum
2019
7.135B
Average
6.70B
Median
2021
Shareholders Equity (Annual) Benchmarks
Gilead Sciences Inc | 22.83B |
Johnson & Johnson | 68.77B |
Eli Lilly and Co | 10.77B |
Merck & Co Inc | 37.58B |
Regeneron Pharmaceuticals Inc | 25.97B |